InsidersTradesSigma
Discover the complete record of transactions filed by McKelligon Brian, Chief Executive Officer. Director active across 1 company, notably Akoya Biosciences, Inc.. Cumulatively, 2 filings have been published. History available since 15 June 2022. The latest transaction was filed on 15 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Brian McKelligon is President and CEO of Akoya Biosciences, Inc. He leads the company and is responsible for its overall strategy and operations. His leadership is crucial for the company's innovation and growth.